Providence Regional Cancer System-Aberdeen — Aberdeen, Washington

Providence Regional Cancer System-Aberdeen is a clinical research site located in Aberdeen, Washington, United States 98520.

Crixeo Health Trust Score: 87/100 (GOOD). This profile has not yet been claimed by the site owner.

Providence Regional Cancer System-Aberdeen has participated in 188 clinical trials with 131 currently active.

Therapeutic areas: Choriocarcinoma, FIGO Stage I Gestational Trophoblastic Tumor, FIGO Stage II Gestational Trophoblastic Tumor.

Sponsors: GOG Foundation, National Cancer Institute (NCI), ECOG-ACRIN Cancer Research Group.

Sponsor Feasibility Report

Trust Score: 87/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Providence Regional Cancer System-Aberdeen?

Providence Regional Cancer System-Aberdeen has a Crixeo Trust Score of 87/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Providence Regional Cancer System-Aberdeen conducted?

Providence Regional Cancer System-Aberdeen has 188 clinical trials on record, with 131 currently active. Their work covers Choriocarcinoma, FIGO Stage I Gestational Trophoblastic Tumor, FIGO Stage II Gestational Trophoblastic Tumor.

Is Providence Regional Cancer System-Aberdeen accredited by Crixeo Health?

Providence Regional Cancer System-Aberdeen has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Providence Regional Cancer System-Aberdeen?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.